Education
About Us
Working with TipRanks
Follow Us
Celon Pharma SA (PL:CLN)
:CLN
CLN Stock Chart & Stats
zł21.70
--
Market closed
zł21.70
--
Day’s Range― - ―
52-Week Rangezł20.85 - zł32.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)15.54K
Market Cap
€1.17B
Enterprise Valuezł1.20B
Total Cash (Recent Filing)€38.98M
Total Debt (Recent Filing)€19.88M
Price to Earnings (P/E)71.3
Beta0.43
Next Earnings
Nov 19, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 27, 2024Dividend Yield0.37%
Share Statistics
EPS (TTM)-0.62
Shares Outstanding53,856,500
10 Day Avg. Volume8,893
30 Day Avg. Volume15,545
Financial Highlights & Ratios
PEG Ratio-2.02
Price to Book (P/B)3.12
Price to Sales (P/S)7.86
P/FCF Ratio-40.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Celon Pharma SA News
CLN FAQ
What was Celon Pharma SA’s price range in the past 12 months?
Celon Pharma SA lowest stock price was zł20.85 and its highest was zł32.00 in the past 12 months.
What is Celon Pharma SA’s market cap?
Celon Pharma SA’s market cap is €1.17B.
When is Celon Pharma SA’s upcoming earnings report date?
Celon Pharma SA’s upcoming earnings report date is Nov 19, 2025 which is in 11 days.
How were Celon Pharma SA’s earnings last quarter?
Celon Pharma SA released its earnings results on Sep 17, 2025. The company reported -zł0.617 earnings per share for the quarter, missing the consensus estimate of N/A by -zł0.617.
Is Celon Pharma SA overvalued?
According to Wall Street analysts Celon Pharma SA’s price is currently Overvalued.
Does Celon Pharma SA pay dividends?
Celon Pharma SA pays a Annually dividend of zł0.298 which represents an annual dividend yield of 0.37%. See more information on Celon Pharma SA dividends here
What is Celon Pharma SA’s EPS estimate?
Celon Pharma SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Celon Pharma SA have?
Celon Pharma SA has 53,856,500 shares outstanding.
What happened to Celon Pharma SA’s price movement after its last earnings report?
Celon Pharma SA reported an EPS of -zł0.617 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Celon Pharma SA?
Currently, no hedge funds are holding shares in PL:CLN
Company Description
Celon Pharma SA
Celon Pharma SA (CLN) is a biotechnology company based in Poland that focuses on the development and commercialization of innovative therapies for cancer and other serious diseases. The company operates primarily in the pharmaceutical sector, specializing in the research, development, and production of both proprietary and partnered drug candidates. Celon Pharma's core products include novel small molecules and biologics aimed at targeting specific pathways involved in cancer progression and treatment resistance.
Technical Analysis
Ryvu Therapeutics SA
―
Captor Therapeutics SA
―
OncoArendi Therapeutics SA
―
Selvita SA
―
Mabion SA
―